Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2021, Vol. 26 ›› Issue (4): 449-453.doi: 10.12092/j.issn.1009-2501.2021.04.013

Previous Articles     Next Articles

New perspectives on the principle of intention to treat in clinical trials#br#

HUANG Lihong 1,6, WANG Ling 3,6, YAN Fangrong 4,6, WEI Zhaohui 2,6, ZHAO Yang 5,6, XIA Jielai 3, CHEN Feng   

  1. 1 Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 2 Department of Biostatistics, Tiger Medical Company, Hangzhou 310053, Zhejiang, China; 3 Department of Health Statistics, School of Preventive Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi, China; 4 Department of Biostatistics, China Pharmaceutical University, Nanjing 211198, Jiangsu, China; 5 Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, China; 6 RWS Panel of Expert Committee on Biostatistics of CSCO
  • Received:2020-10-19 Revised:2020-11-19 Online:2021-04-26 Published:2021-05-11

Abstract: The intention to treat (ITT) principle is widely applied in the randomized controlled trials (RCTs), which is based on the intention to treat a subject (i.e. the planned treatment regimen) rather than the actual treatment given. With the development and progress of clinical trials, ITT principle needs to be reinterpreted. In the standard definition of ITT principle, the intentional grouping of subjects does not specifically refer to randomization, but rather to planned treatment regimen. In non-randomized clinical trials, that subjects agree to be included in a certain treatment regimen is also a type of intention. ITT principles can be applied to evaluate the effectiveness of treatment regimens under patient/doctor determined intentionality in single-arm clinical trials and non-randomized RWS (real world study, RWS). In the practical application, the grouping strategy based on ITT principle should be considered comprehensively according to the research purpose.

Key words: intended to treat, clinical trial, real world study, single-arm trial

CLC Number: